Yueh‐Han Hsu

1.6k citations
37 papers · 431 indexed · h-index 13
Topics
Lipoproteins and Cardiovascular Health (5 papers)Dialysis and Renal Disease Management (5 papers)Antiplatelet Therapy and Cardiovascular Diseases (5 papers)
Partner nations
TaiwanChinaUnited States

In The Last Decade

Yueh‐Han Hsu

36 papers receiving 416 citations

Peers

Yueh‐Han Hsu
Comparison fields: 5 of 92
  • Surgery 89
  • Epidemiology 79
  • Nephrology 74
  • Hepatology 68
  • Rheumatology 56
Replace Alan Martin with:
Alan Martin United States
Loke Meng Ong Malaysia
Anu Gupta United States
Milagros Ortiz Spain
Brian Radbill United States
Ming-Ju Wu Taiwan
Hoseok Koo South Korea
Alicja E. Grzegorzewska Poland
Song-Seng Loke Taiwan
S. Sonkodi Hungary
Yueh‐Han Hsu relative to Alan Martin United States Alan Martin's profile →
Citations per field
00.5×1.5×2.2×
Alan Martin · 1×
Citations per year

Countries citing papers authored by Yueh‐Han Hsu

Since Specialization
Citations

This map shows the geographic impact of Yueh‐Han Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueh‐Han Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueh‐Han Hsu more than expected).

Fields of papers citing papers by Yueh‐Han Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueh‐Han Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueh‐Han Hsu. The network helps show where Yueh‐Han Hsu may publish in the future.

Co-authorship network of co-authors of Yueh‐Han Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yueh‐Han Hsu. A scholar is included among the top collaborators of Yueh‐Han Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueh‐Han Hsu. Yueh‐Han Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 2
4 1
5 1
6 1
7 15
8 5
9 2
10 6
11 5
12 6
13 16
14 14
15 15
16 20
17 25
18 14
19 56
20 12

About Yueh‐Han Hsu

Yueh‐Han Hsu is a scholar working on Nephrology, Orthopedics and Sports Medicine and Cardiology and Cardiovascular Medicine, having authored 37 papers that have together received 431 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (5 papers), Dialysis and Renal Disease Management (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). The work is most often cited by research in Nephrology (74 citations), Hepatology (68 citations) and Rheumatology (56 citations). Yueh‐Han Hsu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Chih‐Cheng Hsu, Wen‐Chen Tsai, Chia‐Hung Kao, Chih‐Hsin Muo, Fung‐Chang Sung, Yu‐Kang Chang, Jia‐Sin Liu, Chih‐Cheng Hsu, Pei‐Tseng Kung and Chunyi Liu. Their work appears in journals such as PLoS ONE, Scientific Reports and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026